Bloom Steven H. 4
4 · Werewolf Therapeutics, Inc. · Filed May 2, 2025
Insider Transaction Report
Form 4
Bloom Steven H.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-01+201,720→ 201,720 totalExercise: $0.87Exp: 2035-04-30→ Common Stock (201,720 underlying)
Footnotes (1)
- [F1]The option was granted as an inducement material to Mr. Bloom's entering into employment with Werewolf Therapeutics, Inc. (the "Company") in accordance with Nasdaq Listing Rule 5635(c)(4). The option has a ten-year term and vests as to 25% on April 16, 2026, the first anniversary of the effective date of Mr. Bloom's employment, and the remaining 75% vests in 36 equal monthly installments thereafter, subject to continued service by Mr. Bloom to the Company or any of its subsidiaries through each applicable vesting date.